Adicet Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Adicet Bio
ACET Stock  USD 1.10  0.02  1.79%   
Adicet Bio financial statements provide useful quarterly and yearly information to potential Adicet Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Adicet Bio financial statements helps investors assess Adicet Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Adicet Bio's valuation are summarized below:
Gross Profit
25 M
Market Capitalization
92.3 M
Enterprise Value Revenue
2.1386
Earnings Share
(1.70)
Quarterly Revenue Growth
(1.00)
There are currently one hundred twenty fundamental signals for Adicet Bio that can be evaluated and compared over time across rivals. All traders should validate Adicet Bio's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 77.3 M in 2024. Enterprise Value is likely to gain to about (54.6 M) in 2024

Adicet Bio Total Revenue

0.0

Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.2 M, Interest Expense of 23.8 K or Selling General Administrative of 34.7 M, as well as many indicators such as Price To Sales Ratio of 12.57, Dividend Yield of 0.0 or PTB Ratio of 0.45. Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
  
Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Adicet Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets215.3 M207.3 M274.3 M
Pretty Stable
Short and Long Term Debt Total19.9 M20.9 M70.8 M
Pretty Stable
Total Current Liabilities18.3 M19.3 M51.2 M
Slightly volatile
Property Plant And Equipment Net46.4 M44.2 M18.3 M
Slightly volatile
Current Deferred Revenue3.6 M5.5 M4.3 M
Slightly volatile
Accounts Payable2.5 M2.6 M22.6 M
Slightly volatile
Cash83.6 M159.7 M80.7 M
Slightly volatile
Non Current Assets Total58.4 M45 M79.2 M
Slightly volatile
Cash And Short Term Investments95.6 M159.7 M93.1 M
Slightly volatile
Common Stock Shares Outstanding28 M43 M26.1 M
Slightly volatile
Non Current Liabilities Total16.9 M17.8 M87.8 M
Very volatile
Other Current Assets2.4 M2.6 M10.9 M
Slightly volatile
Total Liabilities35.3 M37.1 M102.9 M
Slightly volatile
Total Current Assets156.9 M162.3 M195.1 M
Pretty Stable
Intangible Assets1.3 M1.4 M45.5 M
Pretty Stable
Common Stock3.4 K3.6 K131.3 K
Slightly volatile
Net Receivables371.9 K391.5 K69.5 M
Slightly volatile
Short Term Debt5.5 M6.4 M6.2 M
Slightly volatile
Other Assets0.80.90.98
Slightly volatile
Capital Lease Obligations16.9 M20.9 M21.2 M
Slightly volatile
Net Invested Capital240.8 M170.2 M147.6 M
Slightly volatile
Property Plant And Equipment Gross51.9 M59 M36.5 M
Slightly volatile
Capital Stock3.9 K4.6 K2.6 K
Slightly volatile
Non Current Liabilities Other123.5 K130 K750.8 K
Slightly volatile
Net Working Capital200.3 M143 M113.8 M
Slightly volatile

Adicet Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization5.2 M6.1 M5.1 M
Pretty Stable
Interest Expense23.8 K25 K1.5 M
Slightly volatile
Selling General Administrative34.7 M26.5 M42.7 M
Slightly volatile
Other Operating Expenses182.5 M152 M212.3 M
Slightly volatile
Research Development111.3 M106 M30 M
Slightly volatile
Cost Of Revenue5.8 M6.1 M175.9 M
Slightly volatile
Total Operating Expenses159.6 M152 M64.1 M
Slightly volatile
Selling And Marketing Expenses5.2 M5.5 M41.9 M
Slightly volatile
Interest Income10.5 M10 M2.2 M
Slightly volatile
Reconciled Depreciation3.1 M6.1 M1.8 M
Slightly volatile

Adicet Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation21.3 M20.3 M6.8 M
Slightly volatile
Begin Period Cash Flow270.5 M257.7 M82.3 M
Slightly volatile
Depreciation3.4 M6.1 M4.4 M
Slightly volatile
Capital Expenditures3.7 M4.5 M3.5 M
Slightly volatile
End Period Cash Flow84.7 M159.7 M81.8 M
Slightly volatile
Dividends Paid6.5 M8.1 M6.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio12.5713.2349.3334
Pretty Stable
Days Sales Outstanding5.435.72129
Pretty Stable
Stock Based Compensation To Revenue0.50.620.3452
Slightly volatile
Capex To Depreciation0.70.7321.9658
Slightly volatile
EV To Sales4.474.752.5294
Pretty Stable
Inventory Turnover3.752.242.5265
Slightly volatile
Days Of Inventory On Hand212168621
Pretty Stable
Payables Turnover2.212.3233.8882
Slightly volatile
Sales General And Administrative To Revenue0.830.951.2057
Slightly volatile
Research And Ddevelopement To Revenue2.582.572.8284
Slightly volatile
Capex To Revenue0.630.60.3067
Slightly volatile
Cash Per Share2.853.71053.8687
Slightly volatile
Days Payables Outstanding149157798
Pretty Stable
Income Quality0.680.65690.9614
Pretty Stable
Intangibles To Total Assets0.05030.0530.7775
Very volatile
Current Ratio5.218.41357.9894
Slightly volatile
Receivables Turnover54.2951.719.0171
Slightly volatile
Graham Number9.917.170812.6974
Pretty Stable
Capex Per Share0.0960.10370.1028
Slightly volatile
Revenue Per Share0.660.79.6484
Slightly volatile
Interest Debt Per Share0.07110.07482.1526
Slightly volatile
Debt To Assets0.01480.01550.5028
Very volatile
Days Of Payables Outstanding149157798
Pretty Stable
Ebt Per Ebit1.130.93831.0583
Pretty Stable
Long Term Debt To Capitalization0.02480.02610.1574
Slightly volatile
Net Income Per E B T0.610.860.8237
Slightly volatile
Cash Ratio8.698.28084.5795
Slightly volatile
Days Of Inventory Outstanding212168621
Pretty Stable
Days Of Sales Outstanding5.435.72129
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.821.04761.0198
Slightly volatile
Fixed Asset Turnover0.440.46979
Very volatile
Debt Ratio0.01480.01550.5028
Very volatile
Price Sales Ratio12.5713.2349.3334
Pretty Stable
Asset Turnover0.08260.08691.2381
Slightly volatile
Gross Profit Margin0.760.720.5981
Slightly volatile
Operating Cycle281174748
Very volatile

Adicet Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap77.3 M81.4 M478.4 M
Very volatile

Adicet Fundamental Market Drivers

Cash And Short Term Investments159.7 M

Adicet Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Adicet Bio Financial Statements

Adicet Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Adicet Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.5 M3.6 M
Cost Of Revenue6.1 M5.8 M
Stock Based Compensation To Revenue 0.62  0.50 
Sales General And Administrative To Revenue 0.95  0.83 
Research And Ddevelopement To Revenue 2.57  2.58 
Capex To Revenue 0.60  0.63 
Revenue Per Share 0.70  0.66 
Ebit Per Revenue(3.34)(3.51)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY